Wfa Asset Management Corp Merck & Co., Inc. Transaction History

Wfa Asset Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 24, 2024	BUY	$102.95 - $114.33 $45,400 - $50,419	441 New	441 $45.4 Million
Q3 2023 Oct 13, 2023	BUY	$102.95 - $114.33 $205 - $228	2 Added 0.46%	441 $45.4 Million
Q2 2023 Oct 13, 2023	SELL	$108.61 - $118.38 $79,285 - $86,417	-730 Reduced 62.45%	439 $50.6 Million
Q1 2023 Oct 13, 2023	BUY	$102.94 - $114.86 $823 - $918	8 Added 0.69%	1,169 $124 Million
Q4 2022 Oct 13, 2023	BUY	$87.44 - $112.11 $699 - $896	8 Added 0.69%	1,161 $129 Million
Q3 2022 Oct 13, 2023	BUY	$84.53 - $94.96 $760 - $854	9 Added 0.79%	1,153 $99.3 Million
Q2 2022 Oct 13, 2023	BUY	$83.49 - $94.64 $751 - $851	9 Added 0.79%	1,144 $104 Million
Q1 2022 Oct 13, 2023	BUY	$73.51 - $82.4 $661 - $741	9 Added 0.8%	1,135 $93.2 Million
Q4 2021 Oct 13, 2023	BUY	$72.28 - $90.54 $81,387 - $101,948	1,126 New	1,126 $86.3 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Wfa Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Wfa Asset Management Corp with notifications on news.